Precision where it matters most.

Precision where it matters most—at the intersection of imaging, therapy, and operating discipline. We build and run nuclear medicine & theranostics programs end-to-end, so hospitals don’t just adopt a modality—they operationalize a reliable capability that scales across indications and sites.

From regulatory readiness and hot-lab workflows to reporting, QA, and staff training, our teams embed the cadence that turns first scans and first doses into routine, safe, and auditable care.

Set up a theranostics practice

What TPPL does?

We align facility design, AERB licensing, radiopharmacy discipline, staffing models, and RIS/PACS workflows, then stand up day-sheets, downtime playbooks, and escalation paths to keep throughput high and risk low.

From the first RAM(Radioactive Material) authorization to the first treated patient—and the thousand after—we own the details that build trust with clinicians, boards, and regulators alike.

Turnkey Centre Operations
Safety & Compliance
Reporting & QA

Training & Credentialing
Practice Development
Clinical Studies Enablement

Explore Operations & Advisory

Why it works?

Theranostics succeeds on systems: protocols, people, radiopharmacy discipline, scheduling rigor, and auditable reporting. Our methodology hardwires standard work, competency ladders, and closed-loop QA into your daily operations, ensuring reproducibility of outcomes and transparency of risk. We integrate tumour boards, MDT pathways, and referral education so clinical adoption grows naturally around a predictable service line.

Partnership Spotlight

Valentis Cancer Care, Meerut—PET-CT–enabled oncology services with theranostics capability development supported by TPPL.

Our partnership model is hands-on: co-design SOPs, train onsite teams, stabilise schedules, and institute performance dashboards that track utilisation, turnaround, and safety signals.

Outcome: a future-ready programme that moves from imaging excellence to therapy readiness with confidence.

Our People

Nuclear medicine requires convergent expertise:

clinical knowledge of imaging interpretation, understanding of radiopharmaceuticals and tracer behavior, operational precision in protocol implementation, and sustained engagement with regulatory requirements. Finding individuals with depth across all these dimensions is uncommon. TPPL's clinical leadership represents two decades of experience across institutional settings and regulatory environments.

Dr. Ishita B. Sen Director

Director & Head, Nuclear Medicine & Molecular Imaging, Fortis Memorial Research Institute (FMRI),
Gurgaon; 20+ years’ experience.

Dr. Dharmender Malik Director

Senior Consultant, Nuclear Medicine, FMRI; research spans PET/CT, α/β theranostics, and nuclear cardiology, with a focus on practical protocols and measurable QA.